Disease Area | Trademark | Compound | First Registration | Registered no. of Countries | |
---|---|---|---|---|---|
Parkinson's disease | Azilect® | Rasagiline | 2005 | 7 | |
Alcohol dependence | Selincro® | Nalmefene | 2013 | 37 | |
Alzheimer's disease | Ebixa®, Ebix®, Abixa®, Memantine Merz® | Memantine | 2002 | 76 | |
Migraine | Vyepti® | Eptinezumab | 2020 | 52 | |
Epilepsy | Carnexiv® | Carbamazepine | 2016 | 1 | |
Sabril® | Vigabatrin | 1993 | 2 | ||
Onfi®, Frisium® | Clobazam | 1975 | 2 |
Disease Area | Trademark | Compound | First Registration | Registered no. of Countries | |
---|---|---|---|---|---|
Depression, Anxiety | Rexulti®, Rxulti® | Brexpiprazole | 2015 | 62 | |
Brintellix®, Trintellix®, Fonksera®, Vortioson®, Vurtuoso® | Vortioxetine | 2013 | 95 | ||
Cipralex®, Lexapro®, Sipralexa®, Seroplex®, Entact®, Lepax®, Premalex®, Prilect®, Esipram®, Esertia®, Rhea Escitalopram® | Escitalopram Oxalate | 2001 | 100 | ||
Cipramil®, Seropram®, Cipram®, Sepram®, Celexa®, Elopram®, Prisdal® | Citalopram | 1988 | 60 | ||
Deanxit® | Flupentixol + melitracene | 1971 | 19 | ||
Noritren®, Nortrilen®, Sensaval® | Nortriptyline | 1963 | 14 | ||
Saroten®, Sarotex®, Redomex®, Sarotena® | Amitriptyline | 1960 | 9 | ||
Psychosis | Rexulti®, Rxulti® | Brexpiprazole | 2015 | 62 | |
Abilify Maintena® | Aripiprazole | 2013 | 50 | ||
Serdolect® | Sertindol | 1996 | 30 | ||
Cisordinol®, Clopixol®, Ciatyl-Z® | Zuclopenthixol | 1982 | 55 | ||
Cisordinol Depot®, Clopixol Depot®, Ciatyl-Z Depot® | Zuclopenthixoldecanoate | 1976 | 74 | ||
Fluanxol Depot®, Depixol®, Fluanxol LP®, Fluanxol Retard® | Cis(Z)-Flupenticoldecanoate | 1970 | 67 | ||
Fluanxol®, Fluanxol Mite®, Depixol® | Flupentixol | 1965 | 43 | ||
Truxal® | Chlorprothixene | 1959 | 16 | ||
Cisordinol-Acutard®, Clopixol-Acutard®, Clopixol-Acuphase®, Ciatyl-Z-Acuphase® | Zuclopenthixolacetate | 1986 | 65 |
Disease Area | Trademark | Compound | First Registration | Registered no. of Countries | |
---|---|---|---|---|---|
Other | Northera® | Droxidopa | 2014 | 1 | |
Vigil® | Modafinil | 2009 | 1 |
R&D of new and improved treatments is at the core of what we do.
We see patients as people and are committed to support the person behind.
Discover our projects and compounds in development.